Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium phosphates (a combination of dibasic potassium phosphate and monobasic potassium phosphate) is an inorganic salt solution used as a phosphorus replacement therapy. It is primarily indicated for the treatment of hypophosphatemia in adult and pediatric patients weighing 40 kg or more when oral or enteral replacement is not possible, insufficient, or contraindicated. As an intravenous electrolyte replenisher, it provides phosphate ions essential for various metabolic and enzymatic reactions, including the formation of adenosine triphosphate (ATP), calcium homeostasis, and acid-base buffering. It also serves as a source of potassium ions, which are critical for nerve conduction and muscle contraction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium phosphates.